Jaguar Health Q1 2021 Earnings Report

Reported consolidated financial results for the first quarter of 2021, with Mytesi gross sales and net sales increasing.

Key Takeaways

Jaguar Health reported its first quarter 2021 financial results, highlighting a 250% increase in Mytesi gross sales and a 43% increase in net sales.

Mytesi gross sales were approximately $4.6 million, a 250% increase.

Mytesi net sales were approximately $1.2 million, a 43% increase.

The company hosted an investor webcast on May 17, 2021, to discuss the first quarter 2021 financials and business updates.

Jaguar Health is focused on developing novel, plant-based, non-opioid prescription medicines.

Unlock previous datapoints

Unlock previous datapoints

Analyze how earnings announcements historically affect stock price performance

Loading earnings performance data...

Loading earnings reaction data...

Full financial data and analysis